Sotatercept improves right ventricular function but is associated with new or worsening pericardial effusions: a cardiovascular magnetic resonance study in intermediate-high risk pulmonary arterial hypertension

Background: Sotatercept is a novel drug therapy for pulmonary arterial hypertension (PAH) that significantly reduces clinical worsening and improves exercise capacity, functional class, and pulmonary haemodynamics. This study aims to use cardiovascular magnetic resonance (CMR) to monitor the cardiac...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ruta Virsinskaite, Catherine J. Beattie, Nina Karia, Tushar Kotecha, Benjamin E. Schreiber, Jay Suntharalingam, Robert V. MacKenzie Ross, Philip D. Hughes, Julian Lentaigne, Ann M. Scott-Russell, Victoria Parish, Ganesh Kasavkar, Bianca Dumitru, Gavin Thomas, Marianna Fontana, Vivek Muthurangu, J. Gerry Coghlan, Daniel S. Knight
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-01-01
Col·lecció:	Journal of Cardiovascular Magnetic Resonance
Matèries:	Cardiovascular magnetic resonance Pulmonary arterial hypertension Pericardial effusion Right ventricular ejection fraction Right ventricular function Sotatercept
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1097664726000323
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!